MedTrace Logo

Asthma Clinical Research Network (ACRN)

NCT00000577 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2017-01-16

No results posted yet for this study

Summary

This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.

Conditions

Interventions

DRUG

Albuterol

DRUG

Colchicine

DRUG

Adrenal Cortex Hormones

DRUG

Adrenergic-Beta Agonists

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Homer A. Boushey · University of California, San Francisco

  • William Calhoun · University of Pittsburgh at Pittsburgh

  • Mario Castro · Washington University School of Medicine

  • Vernon Chinchilli · Milton S. Hershey Medical Center

  • Elliot Israel · Brigham and Women's Hospital

  • Robert F. Lemanske, Jr. · University of Wisconsin, Madison

  • Richard J. Martin · National Jewish Medical & Research Center

  • Stephen P. Peters · Wake Forest University Health Sciences

  • Stephen I. Wasserman · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-09-30
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000577 on ClinicalTrials.gov